Literature DB >> 23336087

Crosstalk between Nitric Oxide and T helper cells.

Kalipada Pahan1, Susanta Mondal.   

Abstract

Entities:  

Year:  2012        PMID： 23336087      PMCID： PMC3546537     

Source DB:  PubMed          Journal:  J Clin Cell Immunol


× No keyword cloud information.
  21 in total

Review 1.  IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease.

Authors:  Jarod Zepp; Ling Wu; Xiaoxia Li
Journal:  Trends Immunol       Date:  2011-04-12       Impact factor: 16.687

2.  Regulation of encephalitogenicity of neuroantigen-primed T cells by nitric oxide: Implications for multiple sclerosis.

Authors:  Susanta Mondal; Saurav Brahmachari; Kalipada Pahan
Journal:  J Clin Cell Immunol       Date:  2012-07-16

3.  Regulation of type 17 helper T-cell function by nitric oxide during inflammation.

Authors:  Wanda Niedbala; Jose C Alves-Filho; Sandra Y Fukada; Silvio Manfredo Vieira; Akio Mitani; Fabiane Sonego; Ananda Mirchandani; Daniele C Nascimento; Fernando Q Cunha; Foo Y Liew
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

Review 4.  Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system.

Authors:  L Steinman
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

5.  Peroxisome proliferator-activated receptor-alpha and retinoid X receptor agonists inhibit inflammatory responses of astrocytes.

Authors:  Jihong Xu; Janet A Chavis; Michael K Racke; Paul D Drew
Journal:  J Neuroimmunol       Date:  2006-06-09       Impact factor: 3.478

Review 6.  Signals for the induction of nitric oxide synthase in astrocytes.

Authors:  Ramendra N Saha; Kalipada Pahan
Journal:  Neurochem Int       Date:  2006-06-05       Impact factor: 3.921

7.  Neuroimmune pharmacological control of EAE.

Authors:  Kalipada Pahan
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-23       Impact factor: 4.147

8.  IFN-γ limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27.

Authors:  Gopal Murugaiyan; Vanessa Beynon; Andre Pires Da Cunha; Nicole Joller; Howard L Weiner
Journal:  J Immunol       Date:  2012-11-02       Impact factor: 5.422

9.  Gemfibrozil ameliorates relapsing-remitting experimental autoimmune encephalomyelitis independent of peroxisome proliferator-activated receptor-alpha.

Authors:  Subhajit Dasgupta; Avik Roy; Malabendu Jana; Dean M Hartley; Kalipada Pahan
Journal:  Mol Pharmacol       Date:  2007-07-11       Impact factor: 4.436

10.  Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease.

Authors:  M K Racke; A Bonomo; D E Scott; B Cannella; A Levine; C S Raine; E M Shevach; M Röcken
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307
View more
  3 in total

Review 1.  Oxidative Stress and Neurobiology of Demyelination.

Authors:  Srdjan Ljubisavljevic
Journal:  Mol Neurobiol       Date:  2014-12-11       Impact factor: 5.590

2.  Multiple Sclerosis and Experimental Allergic Encephalomyelitis.

Authors:  Kalipada Pahan
Journal:  J Clin Cell Immunol       Date:  2013-09-23

3.  OGR1/GPR68 Modulates the Severity of Experimental Autoimmune Encephalomyelitis and Regulates Nitric Oxide Production by Macrophages.

Authors:  Cheryl A D'Souza; Fei Linda Zhao; Xujian Li; Yan Xu; Shannon E Dunn; Li Zhang
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.